Search results: Sage Journals

Open accessResearch articleFirst published April, 2023

The parable of the Therapeutic Goods Administration approval of esketamine (Spravato) in Australia

William Lugg

Australasian Psychiatry

Free accessOtherFirst published January, 2017

Pharmacogenomics in psychiatry – Clinical innovation utilised by the Therapeutic Goods Administration and Food and Drug Administration

Jayashri Kulkarni

Australian & New Zealand Journal of Psychiatry

Free accessLetterFirst published April, 2018

Should the Australian Therapeutic Goods Administration recommend rapid dosing of lithium carbonate in acute mania?

Klaus Oliver Schubert, Alice Wisdom

Australian & New Zealand Journal of Psychiatry

Restricted accessOtherFirst published January, 2009

The Australian Medicines Regulatory System: A Risk-Based Approach to Regulation

Rohan Hammett, Leonie Hunt

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published September, 2017

The Benefit-Risk Assessment of Medicines

Neil McAuslane, James Leong, Lawrence Liberti [...]

Therapeutic Innovation & Regulatory Science

Free accessLetterFirst published January, 2020

An analysis of the Australian Therapeutic Goods Administration Database of Adverse Event Notifications of diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors in surgical patients

Venkatesan Thiruvenkatarajan, Nagesh Nanjappa, Manesha Sembu [...]

Anaesthesia and Intensive Care

Available accessReview articleFirst published March, 2022

Regulatory scenario of pharmaceutical advertisement in India,USA and Australia: A comparative study

Vikas Budhwar, Tarif Hussian, Manjusha Choudhary [...]

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Restricted accessOtherFirst published January, 2000

Regulation of Complementary Medicines—The Australian Experience

Graham Peachey

Therapeutic Innovation & Regulatory Science

Available accessResearch articleFirst published December, 2015

Regulation Policy for Cell and Tissue Therapies in Australia

Marian Sturm

Tissue Engineering Part A: Research Advances

Available accessResearch articleFirst published October, 2019

Public Engagement for Regulatory Reform: A Case Study of Autologous Stem Cell Therapy Regulation in Australia

Georgia Dempster, Georgina Sutherland, Louise Keogh

Science Communication

Open accessResearch articleFirst published April, 2023

The parable of the Therapeutic Goods Administration approval of esketamine (Spravato) in Australia

William Lugg

Australasian Psychiatry

Free accessOtherFirst published January, 2017

Pharmacogenomics in psychiatry – Clinical innovation utilised by the Therapeutic Goods Administration and Food and Drug Administration

Jayashri Kulkarni

Australian & New Zealand Journal of Psychiatry

Free accessLetterFirst published April, 2018

Should the Australian Therapeutic Goods Administration recommend rapid dosing of lithium carbonate in acute mania?

Klaus Oliver Schubert, Alice Wisdom

Australian & New Zealand Journal of Psychiatry

Restricted accessOtherFirst published January, 2009

The Australian Medicines Regulatory System: A Risk-Based Approach to Regulation

Rohan Hammett, Leonie Hunt

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published September, 2017

The Benefit-Risk Assessment of Medicines

Neil McAuslane, James Leong, Lawrence Liberti [...]

Therapeutic Innovation & Regulatory Science

Free accessLetterFirst published January, 2020

An analysis of the Australian Therapeutic Goods Administration Database of Adverse Event Notifications of diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors in surgical patients

Venkatesan Thiruvenkatarajan, Nagesh Nanjappa, Manesha Sembu [...]

Anaesthesia and Intensive Care

Available accessReview articleFirst published March, 2022

Regulatory scenario of pharmaceutical advertisement in India,USA and Australia: A comparative study

Vikas Budhwar, Tarif Hussian, Manjusha Choudhary [...]

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Restricted accessOtherFirst published January, 2000

Regulation of Complementary Medicines—The Australian Experience

Graham Peachey

Therapeutic Innovation & Regulatory Science

Available accessResearch articleFirst published December, 2015

Regulation Policy for Cell and Tissue Therapies in Australia

Marian Sturm

Tissue Engineering Part A: Research Advances

Available accessResearch articleFirst published October, 2019

Public Engagement for Regulatory Reform: A Case Study of Autologous Stem Cell Therapy Regulation in Australia

Georgia Dempster, Georgina Sutherland, Louise Keogh

Science Communication